Mirae Asset Global ETFs Holdings
OVID icon

Mirae Asset Global ETFs Holdings’s Ovid Therapeutics OVID Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
+86,098
New +$222K ﹤0.01% 2405
2025
Q2 		– Sell
-37,012
Closed -$11.5K – 3176
2025
Q1 		$11.5K Buy
37,012
+1,482
+4% +$911 ﹤0.01% 3017
2024
Q4 		$33.2K Buy
35,530
+1,444
+4% +$1.62K ﹤0.01% 2957
2024
Q3 		$40.2K Buy
34,086
+3,173
+10% +$3.31K ﹤0.01% 2962
2024
Q2 		$23.8K Buy
+30,913
New +$86K ﹤0.01% 2904

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's OVID Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 86,098 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #2405 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in OVID as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in OVID in Q2 2024 and has held it in 5 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 86,098 shares of Ovid Therapeutics worth $232K as of Q2 2026.
  • Ovid Therapeutics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2405 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Ovid Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.